Topic Listing for Baxter International

Accounts Other Receivable Reserves Accounts Payable Accrued Liabilities
Accounts Receivable Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income Aoci Accumulated Other Comprehensive Loss
Acquisitions Acquisitions Investments Advances Affiliates
Additional Contributed Capital Adjustments Restructuring Charges
Adopted Pursuant 906 Sarbanes-oxley Act 2002 Adoption Sfas 123-r
Adoption Sfas 158 Allowance Doubtful Accounts
Althane Dialyzers Litigation Amendment
Amendment Qualified Defined Benefit Pension Plan Contribution American Jobs Creation Act 2004
Amounts Expected Amortized Aoci Net Periodic Benefit Cost Amounts Recognized Aoci 2006
Anesthesia Annual Assessment Board Committee Performance
Annual Meeting Annual Meeting Shareholders Chicago Cultural Center
Antibody Therapy Assessment Internal Control Over Financial Reporting
Assets Reconciliation Attending Annual Meeting
Audit Committee Audit Committee Report
Audit Non-audit Fees Autros
Available Information Balance Sheet
Base Salaries Basis Consolidation
Baxter Announces Key Executive Appointments Page Baxter Healthcare Corporation World Trade Executive Officers
Baxter International Inc Baxter International Inc Executive Officers
Baxter International Inc Names Peter Hellman Board Directors Baxter Reports 4th Results Page
Baxter Reports Results Page Baxter Restate Page
Baxters Peer Group Data Baxters Repatriation Plans-page
Baxters Stock Ownership Guidelines Executive Officers Directors Beneficial Ownership Reporting Compliance
Best Investor Bioscience
Blake Devitt Board Directors
Board Directors Statement Opposing Shareholder Resolution Board Directors Statement Opposing Stockholder Resolution
Board Directors Statement Regarding Stockholder Resolution Book Values Fair Financial Instruments
Business Development Activities Unsuccessful Suffer Financial Performance Adversely Business Segments
Capital Expenditures Cash Bonuses
Cash Collateral Requirements Cash Compensation
Cash Dividends Declared Per Common Share Cash Equivalents
Cash Equivalents Beginning Cash Flow Hedges
Cash Flow Information Cash Flows
Cash Flows Continuing Operations Cash Flows Financing Activities
Cash Flows Investing Activities Cash Flows Operations
Certain Relationships Related Transactions Certification Chief Executive Officer Pursuant Rules 13a-14 15d-14
Certification Chief Executive Officer Pursuant Usc 1350 Adopted Certification Chief Financial Officer Pursuant Rules 13a-14 15d-14
Certification Chief Financial Officer Pursuant Usc 1350 Adopted Chairman Chief Executive Officer
Change Control Changes Accounting Principles
Changes Internal Control Over Financial Reporting Charges
Code Conduct Code Ethics
Colleague Matter Commitments Contingencies
Committees Board Common Stock
Common Stock Dividends Common Stock Information
Common Stock Treasury Communicating Board Directors
Compensation Committee Compensation Committee Interlocks Insider Participation
Compensation Committee Report Compensation Directors
Compensation Discussion Analysis Compensation Elements
Compensation Philosophy Compensation Philosophy Officers
Competition Competitors Develop Effective Affordable Products Achieve Earlier Patent
Competitors Several Significantly Greater Financial Other Resources Compliance Securities Exchange Act 1934
Comprehensive Income Concentrations Risk
Consent Independent Registered Public Accounting Firm Consolidated Financial Statements
Consolidation Healthcare Industry Adversely Affect Business Financial Condition Contacting Lead Director Other Members Board
Contractual Arrangements Contractual Obligations
Controls Procedures Corporate Governance
Corporate Governance Committee Corporate Governance Guidelines
Corporate Headquarters Cost Proxy Solicitation
Credit Commitments Credit Facilities
Credit Facilities Access Capital Commitments Credit Facilities Access Capital Commitments Contingencies
Credit Facilities Access Capital Net Investment Hedges Credit Facilities Access Capital Ratings Net Investment Hedges
Credit Rating Requirements Credit Ratings
Critical Accounting Policies Cross-currency Swap Agreements
Currency Risk Current Assets
Current Liabilities Customer Inquiries
Debt Issuances Net Payments Obligations Debt Issuances Net Redemptions Other Payments
Debt Issuances Net Redemptions Other Payments Financing Obligations Debt Outstanding
Decrease Increase Cash Equivalents Deferred Tax Asset Valuation Allowances Reserves Uncertain Positions
Deferred Tax Assets Liabilities Defined Contribution Plan
Delaware Departure Directors Principal Officers Election Appointment
Derivatives Hedging Activities Description Business
Description Certain Awards Granted 2007 Description Certain Awards Granted 2008
Devitt Appointed Baxters Board Page Directions 2008 Annual Meeting Shareholders Chicago Cultural Center
Director Biographies Director Candidates Recommended Stockholders
Director Compensation Director Independence
Director Stock Ownership Guidelines Directors Continuing Office Term Expires 2006
Directors Continuing Office Term Expires 2007 Directors Continuing Office Term Expires 2009
Directors Continuing Office Term Expires 2010 Directors Continuing Office Term Expires 2011
Directors Officers Disclosure Controls Procedures
Discount Rate Assumption Divestitures Other
Dividend Reinvestment Documents Incorporated Reference
Drug Delivery Earnings Cash Flow Previously Reported 2001 Through 2004
Earnings Eps 036 Sales Growth Percent Earnings Per Basic Common Share
Earnings Per Diluted Common Share Earnings Per Share
Effect Foreign Exchange Rate Changes Cash Equivalents Effect One-percent Change Assumed Healthcare Cost Trend Rate
Effective Income Tax Rate Election Directors-proposal Proxy Card
Electronic Dissemination Future Proxy Materials Employee Benefit Plan Expenses
Employee Stock Purchase Plans Employment Agreement Chairman Chief Executive Officer
Employment Agreement Robert Parkinson Employment Arrangement David Drohan
Entry Material Definitive Agreement Equity Awards
Equity Compensation Plan Information Equity Forward Agreements
Erythropoietin Epomax Estimates
Evaluation Disclosure Controls Procedures Exact Name Registrant Specified Charter
Examinations Tax Returns Executive Compensation
Executive Compensation Recoupment Policy Executive Management
Executive Officers Registrant Executive Sessions
Exercise Price Exhibits Filed Furnished Securities Exchange
Exhibits Filed Securities Exchange Expected Net Pension Opeb Plan Payments Next
Expected Pension Opeb Plan Funding Expiration
Explanatory Face Substantial Competition Competitors Significantly Greater Financial Other
Failure Provide Quality Products Services Customers Adverse Effect Fair Value Hedges
Fasb 150 Fin
Finance Committee Financial Guidance 2005
Financial Instrument Market Risk Financial Statement Schedule
Financial Statements Exhibits Financial Statements Supplementary Data
Financing Activities Fixed Stock Option Plans
Foreign Currency Interest Rate Risk Management Foreign Currency Translation
Foreign Exchange Forward Option Contracts Form 10-k
Form 10-q Former Name Address Changed Since Last Report
Forward-looking Information Full-year 2004 Results
Full-year 2005 Outlook Funding Pension Opeb Plans
Future Minimum Lease Payments Debt Maturities Future Stockholder Proposals Nominations
Generates Cash Flow Operations 2004 Global Business Practice Standards
Global Business Practice Standards Corporate Responsibility Office Global Stock Option Plan
Goodwill Government Regulation
Gross Margin Gross Margin Expense Ratios
Hedges Hedges Net Investments Foreign Operations
Hedging Activities Immediate Release
Impairment Assets Impairment Reviews
Important Notice Regarding Availability Proxy Materials Annual Meeting Including Area Code
Income Before Tax Expense Category Income Continuing Operations
Income Continuing Operations Before Cumulative Effect Accounting Changes Income Continuing Operations Related Per Diluted Share Amounts
Income Earnings Per Diluted Share Continuing Operations Income Tax Expense
Income Tax Expense Reconciliation Income Taxes
Indemnifications Index
Industry Overview Information
Information Resources Infusion Pump Charge
Infusion Systems Insurance Coverage
Intellectual Property Interest Other Expense Net
Interest Rate Other Risks Internal Control Over Financial Reporting
International Markets Introduction
Inventories Investor Relations
Issuances Stock Joint Development Commercialization Arrangements
Key Financial Objectives Results Lead Director
Leases Legal Contingencies
Legal Proceedings Liabilities
Liabilities Including Restructuring Payments Contributions Pension Trust Liabilities Including Restructuring Payments Contributions Pension Trusts
Liquidity Capital Resources Long-term Debt Lease Obligations
Long-term Incentives Looking Forward
Mammary Implant Litigation Managements Discussion Analysis Financial Condition Results Operations
Managements Report Internal Control Over Financial Reporting Managements Responsibility Consolidated Financial Statements
Market Competitive Compensation Marketing Administrative Expenses
Material Impairments Medicare Prescription Drug Improvement Modernization Act
Medication Delivery Membership Criteria Non-employee Directors
Nature Operations Net Interest Expense
Net Investment Hedges Net Pension Other Postemployment Benefits Expense
Net Pension Other Postretirement Benefits Cost Net Periodic Benefit Cost
Net Sales New Accounting Disclosure Standards
New Accounting Standard New Accounting Standards
Nomination Directors Nominee Election Director Term Expires 2007
Nominees Election Directors Term Expires 2008 Nominees Election Directors Term Expires 2011
Nominees Election Directors Term Expires 2012 Non-employee Director Compensation Plan
Non-reliance Previously Issued Financial Statements Related Audit Nonqualified Deferred Compensation
Notes Referred Above Not Being Registered Securities Act Notice Annual Meeting
Notice Annual Meeting Shareholders Number 1-4448
Oaks Suite Off-balance Sheet Arrangements
Operating Results Operations
Option Exercises Stock Vested Other
Other Assets Other Assumptions
Other Commitments Contingencies Other Director Compensation
Other Events Other Expense Net
Other Financing Activities Other Foreign Currency Hedges
Other Income Expense Other Information
Other Intangible Assets Other Long-term Assets
Other Long-term Liabilities Other Named Executive Officers
Other Special Charges Other Stock Option Grants Not Approved Shareholders
Other Supplemental Information Overview
Overview Managements Discussion Analysis Parking
Parkinsons 2004 Compensation Part
Patent Litigation Pathogen Inactivation Program Assets
Peer Group Data Pension Other Postemployment Benefit Plans
Pension Plan Asset Allocations Pension Plan Assets
Pension Plan Expenses Performance Graph
Perquisites Peter Arduini Named President Medication Delivery
Plasma Proteins Plasma-based Therapies Litigation
Please Proxy Indicated Reverse Side Vote Wish Accordance Post-termination Compensation
Potential Additional Purchase Price Payments Relating Acquisitions Potential Contingent Purchase Price Payments Relating Acquisitions
Pre-approval Audit Permissible Non-audit Services Pre-tax Income
Pre-tax Income Reconciliation Preflucel Influenza Vaccine
President Pricing
Prioritization Charge Process Identifying Evaluating Director Nominees
Product Liability Product Warranties
Progress Begins Step Projected 2005 Pension Opeb Plan Expense
Property Plant Equipment Net Proposal Ratification Independent Registered Public Accounting Firm
Proposal Shareholder Relating Animal Testing Proxy Solicited Behalf Board Directors Baxter International Inc
Proxy Statement Public Policy Committee
Pursuant Exchange Act Rule 13a-14 15d-14 Pursuant Requirements Securities Exchange Act 1934 Registrant Duly
Pursuant Requirements Securities Exchange Act 1934 Report Been Quality Management
Quarterly Period 2004 Quarterly Period 2005
Ratification Appointment Independent Registered Public Accounting Firm-proposal Proxy Raw Materials
Receivable Securitization Arrangements Receivable Securitizations
Reclassifications Revisions Recombinants
Reducing Mailing Expenses Registrants Telephone Number Including Area Code
Regulation Disclosure Reimbursement Current Future Products Reduced Modified Business Suffer
Relationship Executive Compensation Performance Renal
Report Independent Registered Public Accounting Firm Report Independent Registered Public Accounting Firm Financial Statement
Research Development Research Development Costs
Restatement Previously Issued Consolidated Financial Statements Restatements Previously Issued Consolidated Financial Statements
Restricted Stock Restricted Stock Plans
Restricted Stock Units Restructuring Charge
Restructuring Charges Restructuring Charges Net
Restructuring Initiatives Restructuring Reserves
Results Operations Financial Condition Retained Earnings
Retirement Other Benefit Programs Retirement Other Benefits
Return Plan Assets Assumption Revenue Recognition
Revenue Recognition Provisions Bad Debt Revenue Recognition Related Provisions Allowances
Review Review Independent Registered Public Accounting Firm
Salaries Sale Transfusion Therapies Business
Sales Distribution Sarbanes-oxley Act 2002
Schedule Securities Exchange Act 1934
Securities Laws Securities Laws Other
Securities Registered Pursuant Act Securitization Arrangements
Securitizations Security Ownership Certain Beneficial Owners
Security Ownership Directors Executive Officers Segment Information
Selected Financial Data Separation Agreement Harry Kraemer
Sfas 150 Shared Investment Plan
Shareholder Proposal Shareholder Proposals 2009 Annual Meeting
Shareholder Proposals 2010 Annual Meeting Shareholders Equity
Shareholders Statement Supporting Proposed Resolution Shipping Handling Costs
Short-term Debt Current Maturities Long-term Lease Obligations Signatures
Significant Debt Issuances Repurchases Redemptions Significant Product Sales
Six-month Results Special Charges
State Other Jurisdiction Incorporation Stock Compensation Plans
Stock Exchange Listings Stock Option Activity
Stock Option Exercises Stock Option Grant
Stock Option Grants Stock Option Plans
Stock Options Stock Options Outstanding
Stock Ownership Largest Stockholder Stock Repurchase Programs
Stock-based Compensation Stock-based Compensation Plans
Stockholder Proposal Stockholder Proposal Relating Annual Election Directors Proxy Card
Stockholder Proposal Relating Cumulative Voting Election Directors Proxy Stockholder Proposal Relating Restrictions Services Performed Independent Auditors
Stockholders Statement Supporting Proposed Resolution Strong Investor Concern
Subject Foreign Currency Exchange Risk Subject Number Existing Laws Regulations Non-compliance Adversely Affect
Subject Number Existing Laws Regulations Non-compliance Certain Adversely Subject Risks Associated Doing Business Globally
Subsequent Event Decision Cease Manufacturing Hemodialysis Instruments Subsequent Event-decision Cease Manufacturing Hemodialysis Instruments
Summary Significant Accounting Policies Synthetic Leases
Tabl Contents Table Contents
Tax Incentives Therapies
Therapy Total Current Assets
Total Current Liabilities Total Liabilities Shareholders Equity
Total Other Assets Total Shareholders Equity
Transfer Agent Registrar Transfusion Therapies
Unable Obtain Sufficient Components Raw Materials Timely Basis Unable Protect Patents Other Proprietary Rights Infringe Others
Unable Successfully Introduce New Products Fail Keep Pace Unsuccessful Identifying Growth Opportunities Exiting Low Margin Businesses
Unsuccessful Identifying Growth Opportunities Invest Exiting Low Margin Vaccines Litigation
Vesting Vote Important Please Immediately
Vote Mail Sign Date Proxy Card Below Return Weighted-average Assumptions Used Determining Benefit Obligations
Weighted-average Assumptions Used Determining Benefit Obligations Measurement Date Weighted-average Number Common Shares Outstanding
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki